473 related articles for article (PubMed ID: 3138683)
1. Misoprostol and gastroduodenal mucosal protection (cytoprotection).
Wilson DE
Postgrad Med J; 1988; 64 Suppl 1():7-11. PubMed ID: 3138683
[TBL] [Abstract][Full Text] [Related]
2. The therapeutic efficacy of misoprostol in peptic ulcer disease.
Watkinson G; Hopkins A; Akbar FA
Postgrad Med J; 1988; 64 Suppl 1():60-77. PubMed ID: 3138682
[TBL] [Abstract][Full Text] [Related]
3. Antisecretory and mucosal protective actions of misoprostol. Potential role in the treatment of peptic ulcer disease.
Wilson DE
Am J Med; 1987 Jul; 83(1A):2-8. PubMed ID: 3113241
[TBL] [Abstract][Full Text] [Related]
4. Treatment and prevention of NSAID induced gastroduodenal mucosal damage.
Agrawal NM; Saggioro A
J Rheumatol Suppl; 1991 Mar; 28():15-8. PubMed ID: 1674754
[TBL] [Abstract][Full Text] [Related]
5. Protective effects against alcohol insult: does somatostatin play any role?
Agrawal NM; Godiwala T; Arimura A; Groot K; Dajani E
Postgrad Med J; 1988; 64 Suppl 1():15-20. PubMed ID: 2901743
[TBL] [Abstract][Full Text] [Related]
6. Misoprostol: a prostaglandin for peptic ulcer.
DiPalma JR
Am Fam Physician; 1989 Aug; 40(2):217-9. PubMed ID: 2502901
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandins: mucosal protection and peptic ulceration.
Hawkey CJ
Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():45-51. PubMed ID: 2657288
[TBL] [Abstract][Full Text] [Related]
8. Misoprostol heals gastroduodenal injury in patients with rheumatoid arthritis receiving aspirin.
Roth S; Agrawal N; Mahowald M; Montoya H; Robbins D; Miller S; Nutting E; Woods E; Crager M; Nissen C
Arch Intern Med; 1989 Apr; 149(4):775-9. PubMed ID: 2495779
[TBL] [Abstract][Full Text] [Related]
9. Misoprostol in peptic ulcer disease.
Watkinson G; Akbar FA
Prostaglandins; 1987; 33 Suppl():78-92. PubMed ID: 3122278
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of mucosal lesions in the stomach and duodenum due to chronic use of NSAID in patients with rheumatoid arthritis or osteoarthritis, and interim report on prevention by misoprostol of diclofenac associated lesions.
Geis GS; Stead H; Wallemark CB; Nicholson PA
J Rheumatol Suppl; 1991 Mar; 28():11-4. PubMed ID: 1903808
[TBL] [Abstract][Full Text] [Related]
11. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
Bianchi Porro G; Lazzaroni M; Petrillo M
Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
[TBL] [Abstract][Full Text] [Related]
12. [Prostaglandins and the prevention of non-steroidal antirheumatic drug-induced gastric lesions].
Miederer SE
Fortschr Med; 1989 Mar; 107(10):63-4, 67-8. PubMed ID: 2497057
[TBL] [Abstract][Full Text] [Related]
13. Peptic ulcer disease, cytoprotection, and prostaglandins.
Fiske SC
Arch Intern Med; 1988 Oct; 148(10):2112-3. PubMed ID: 3140751
[No Abstract] [Full Text] [Related]
14. Options in the treatment and prevention of NSAID-induced gastroduodenal mucosal damage.
Agrawal NM; Dajani EZ
J Rheumatol Suppl; 1990 Feb; 20():7-11. PubMed ID: 1969964
[TBL] [Abstract][Full Text] [Related]
15. Protective effects of prostaglandins against nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury.
Dajani EZ; Agrawal NM
Int J Clin Pharmacol Res; 1989; 9(6):359-69. PubMed ID: 2699464
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of gastric and duodenal damage and protection.
Hudson N; Hawthorne AB; Cole AT; Jones PD; Hawkey CJ
Hepatogastroenterology; 1992 Feb; 39 Suppl 1():31-6. PubMed ID: 1577394
[TBL] [Abstract][Full Text] [Related]
17. [Therapy and prevention of peptic lesions by prostaglandins].
Müller P; Dammann HG; Simon B
Z Gastroenterol; 1987 Aug; 25 Suppl 3():166-74. PubMed ID: 3116777
[TBL] [Abstract][Full Text] [Related]
18. Cytoprotection of gastroduodenal mucous membrane with analogues of prostaglandins.
Lauritsen K; Laursen LS; Rask-Madsen J
Recenti Prog Med; 1989 Jun; 80(6):344-52. PubMed ID: 2672199
[TBL] [Abstract][Full Text] [Related]
19. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
Lanza F; Peace K; Gustitus L; Rack MF; Dickson B
Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
[TBL] [Abstract][Full Text] [Related]
20. A double-blind placebo-controlled comparison of the efficacy and safety of 50, 100, and 200 micrograms of misoprostol QID in the prevention of ibuprofen-induced gastric and duodenal mucosal lesions and symptoms.
Lanza FL; Fakouhi D; Rubin A; Davis RE; Rack MF; Nissen C; Geis S
Am J Gastroenterol; 1989 Jun; 84(6):633-6. PubMed ID: 2499187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
